EUVIMEDEUVIMED entdecken
Open Access

A novel small-molecule inhibitor GSK-F1 confers radiosensitivity by inhibiting the NSUN2/TP53/RAD51 axis-mediated DNA homologous recombination repair in nasopharyngeal carcinoma

Lemei Zheng, Mengna Li, Xiaolong Li, Jianxia Wei, Changning Xue, Qingqing Wei, Yumei Duan, Huizhen Xin, Zubing Wu, Ting Zeng, Wei Xiong, Songqing Fan und 2 weitere

International Journal of Biological Sciences · 30.03.2026 · 22 (8) · 4043-4058

DOI: 10.7150/ijbs.130087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 30.03.2026. Verfasst von Lemei Zheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Carcinogenesis, Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Sc…. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Tumor Suppressor Protein p53, Rad51 Recombinase, Radiation Tolerance. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasopharyngeal CarcinomaTumor Suppressor Protein p53Rad51 RecombinaseRadiation ToleranceNasopharyngeal NeoplasmsRecombinational DNA RepairHumansCell Line, TumorApoptosisAnimals

Stichwörter der Autor:innen

DNA damageNSUN2RAD51TP53UCHL3nasopharyngeal carcinoma

Substanzen

Tumor Suppressor Protein p53Rad51 RecombinaseRAD51 protein, humanTP53 protein, human

Autor:innen und Institutionen

  • NHC Key Laboratory of Carcinogenesis, Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
  • Cancer Research Institute, School of Basic Medical Sciences, Central South University, Changsha 410078, China.
  • The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Central South University, Changsha 410078, China.
  • Department of Pathology, the Second Xiangya Hospital, Central South University, Changsha 410011, China.

Zitieren

APA

Zheng, L., Li, M., Li, X., Wei, J., Xue, C., Wei, Q., Duan, Y., Xin, H., Wu, Z., Zeng, T., Xiong, W., Fan, S., Zhou, M., & Deng, H. (2026). A novel small-molecule inhibitor GSK-F1 confers radiosensitivity by inhibiting the NSUN2/TP53/RAD51 axis-mediated DNA homologous recombination repair in nasopharyngeal carcinoma. International Journal of Biological Sciences, 22(8), 4043-4058. https://doi.org/10.7150/ijbs.130087

Vancouver

Zheng L, Li M, Li X, Wei J, Xue C, Wei Q, et al. A novel small-molecule inhibitor GSK-F1 confers radiosensitivity by inhibiting the NSUN2/TP53/RAD51 axis-mediated DNA homologous recombination repair in nasopharyngeal carcinoma. International Journal of Biological Sciences. 2026;22(8):4043-4058. doi:10.7150/ijbs.130087

BibTeX
@article{Zheng2026,
  author = {Zheng, Lemei and Li, Mengna and Li, Xiaolong and Wei, Jianxia and Xue, Changning and Wei, Qingqing and Duan, Yumei and Xin, Huizhen and Wu, Zubing and Zeng, Ting and Xiong, Wei and Fan, Songqing and Zhou, Ming and Deng, Hongyu},
  title = {A novel small-molecule inhibitor GSK-F1 confers radiosensitivity by inhibiting the NSUN2/TP53/RAD51 axis-mediated DNA homologous recombination repair in nasopharyngeal carcinoma},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  volume = {22},
  number = {8},
  pages = {4043--4058},
  doi = {10.7150/ijbs.130087}
}
Kostenlos starten →